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Objective: The aim of this study was to measure apolipoprotein-A1 and apolipoprotein-B serum 
concentrations during a physical activity program. Serum apolipoprotein concentrations may be 
a more sensitive indicator of coronary heart disease (CHD) risk than total cholesterol, 
triglycerides, low density lipoproteins and high density lipoproteins. Design: Thirty-seven 
sedentary, healthy adult males were randomly allocated to an exercise group (n=20) who 
underwent 12 weeks of aerobic physical activity or a sedentary group (n=17) who acted as non-
exercising controls. Results: The exercise group increased their aerobic capacity (from 33±4 
mL•kg-1•min-1 to 40±4 mL•kg-1•min-1) but the sedentary group did not. The percentage of 
body fat decreased in the exercise group (from 21.8% to 19.5%) but remained unchanged in the 
sedentary group. Serum cholesterol, lipoprotein and apolipoprotein concentrations did not 
change but serum triglyceride concentrations were reduced in the exercise group (from 1.8±1.3 
mmol•L-1 to 1.2±0.4 mmol•L-1, p<0.05). The Apo-A1:Apo-B ratio increased in the exercise 
group (from 1.17±0.22 to 1.4±0.27, p<0.05) but not in the sedentary group. Conclusion: 
Apolipoprotein concentrations in sedentary males are no more sensitive than other serum lipid 
concentrations but are appropriate for monitoring CHD risk-factor change during short-term 
light exercise interventions.  
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Serum lipid concentrations are often used to evaluate 
the risk of coronary heart disease (CHD). Previous 
studies have shown that low serum concentrations of 
high density lipoproteins (HDL) together with high 
serum concentrations of total cholesterol, triglycerides 
and lipoproteins are associated with an increased risk 
of CHD (1). Other findings have suggested that the 
serum concentration of apolipoproteins may be a more 
specific and sensitive indicator of CHD risk (2, 3). 
Apolipoprotein A-1 (Apo-A1), the major protein  
 
component of HDL, is thought to have antiatherogenic 
potential, whereas apolipoprotein B (Apo-B), the 
major protein component of low density lipoprotein 
(LDL), is believed to play an important role in 
atherogenesis (4, 5). Apo-B concentration also appears 
to be a good indicator of circulating atherogenic 
particles and a potentially useful method of evaluating 
cholesterol transport and independent CHD risk (6). 
Various studies have indicated that total cholesterol is 
a less sensitive marker of CHD risk than measured 
fractions of HDL and LDL; total cholesterol is an even 
less accurate indicator of CHD risk than 
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concentrations of Apo-A1 and Apo-B (6, 7). Ratios 
between certain circulating lipids are often used to 
evaluate CHD risk in addition to absolute 
concentrations. For example, it has been suggested 
that the lower the Apo-A1:Apo-B ratio the greater the 
risk of CHD (6). Furthermore, the oxidized 
phospholipid:Apo-B ratio has been positively 
correlated with the presence and extent of coronary 
artery disease on angiographic examination (8).  
Previous studies have shown that habitual physical 
activity helps reduce CHD risk factors, particularly in 
relation to total cholesterol, triglyceride and 
lipoprotein concentrations (9, 10). Several studies have 
investigated the effects of combined exercise and diet 
on Apo-A1 in the context of weight loss (11, 12) but 
few have looked at the effects of physical activity 
alone. Those that have produced inconsistent findings 
(9, 13) and were limited to Apo-A1 changes among 
hypercholesterolaemic subjects (14). Epidemiological 
studies focusing on physical activity and 
cardiovascular risk have reported an inverse 
relationship between high levels of physical activity 
and Apo-B concentrations in young males (15) as well 
as a positive relationship between physical fitness and 
HDL:Apo-A1 ratios (16) and favorable levels of both 
Apo-A1 and Apo-A1:Apo-B ratios in males and 
females with high levels of physical activity (17). 
Comparisons between highly active, moderately 
active, and inactive Japanese males indicated that 
physical activity may have a greater effect on Apo-A1 
than other lipid sub fractions, with Apo-A1 levels 
increasing in proportion to the amount of physical 
activity (17).  
Although the Apo-A1:Apo-B ratio is a potentially 
effective tool to monitor changes in risk among CHD 
patients undertaking prescribed physical activity, what 
has not been established is whether apolipoprotein 
concentrations can be used to evaluate changing risk 
among otherwise healthy sedentary people 
undertaking mild physical activity. The aim of this 
study was to measure the extent to which 
apolipoprotein concentrations are sensitive to mild 
increases in physical activity. It was hypothesized that 
mild aerobic exercise among previously sedentary 
males would provoke an increase in serum Apo-A1 
concentration and an increased Apo-A1:Apo-B ratio. 
 
MATERIAL AND METHODS 
 
Design and Participants 
 
A between-subjects experimental design was used in 
which thirty-seven sedentary, healthy male 
participants were randomly assigned to either an 
exercise condition (n = 20, age 42.4 ± 1.4 years, height 
177.7 ± 1.2 cm and body mass 80.6 ± 1.9 kg) or a no 
exercise control condition (n = 17, age 44.5 ± 1.5 
years, height 175.7 ± 1.7 cm and body mass 85.7 ± 3.3 
kg). A power analysis for an ANOVA design with two 
independent groups and three measurement trials was 
performed for sample size estimation using the SAS 
macro program FPOWER.SAS. The outcome 
indicated that 18 participants per condition (30 total) 
would be needed to achieve a statistical power of >0.8 
assuming a moderate effect size of 0.6. 
Participants had no recorded history of medical 
problems and had not participated in sports or exercise 
during the six months preceding the study. Only 
aerobically unfit participants were included in this 
study. Volunteers with a peak oxygen uptake of 
greater than 40 ml•kg-1•min-1 were also excluded. 
Participants provided their written informed consent to 
participate in the study. All of the procedures used 
were approved by the University of Wollongong ethics 
committee and conducted in accordance with the 




Participant measurements were taken prior to the 
intervention (week 0), halfway through the 
intervention (week 6) and at the end of the 
intervention (week 12). On each occasion participants’ 
anthropometric profiles were measured, resting heart 
rate and blood pressure measurements were taken, a 
blood sample was taken for lipid analysis and an ECG 
stress test incorporating a  test was conducted. A 24-
hour diet recall was completed by each participant for 
the period immediately prior to each testing session to 
establish any differences in participants’ diets. 
Participants were asked to refrain from smoking for at 
least one hour prior to each exercise test and to fast for 
12-16 hours in preparation for the serum lipid 
analyses. Originally, twenty participants were 
recruited for each group, but three subjects from the 
sedentary group were subsequently excluded from the 
study after they reported that they had taken up 
physical activity or had markedly modified their diets 
as indicated by the 24-hour dietary recalls. 
 
Body Composition and Anthropometric 
Testing 
 
Participants’ height was measured using a stadiometer 
(Somatometre 211daPD, USA) and body mass was 
measured using calibrated portable scales (Scout 2, 
Ohaus, USA). Four site skinfold measurements 
(triceps, subscapular, suprailiac, and medial calf) were 
taken by a qualified anthropometrist using Harpenden 
skinfold calipers (Harpenden, West Sussex, UK). All 
skinfold measurements were taken to the nearest 
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0.1mm and an average of three readings for each site 
was used. Skinfold measurements were used to 
estimate the percentage of body fat using previously 




In each subject a fasting venous blood sample was 
taken from the antecubital vein immediately prior to 
the stress test. This blood sample was analyzed for 
total serum cholesterol (CHOL), triglyceride (TRIG), 
HDL, LDL, Apo-A1 and Apo-B. With the exception 
of Apo-A1 and Apo-B, the serum concentration of 
each component was determined using an Ektachem 
DT6O analyzer (Kodak, USA). Apo-A1 and Apo-B 
concentrations were measured using a Beckman Array 
Protein System (Beckman, USA). 
 
Stress Testing and Cardiovascular Analysis 
 
Each participant performed a stress test during which 
aerobic capacity was measured using an integrated 
Quinton cardiac stress testing system (Q-5000 
EKG/Stress Test System, USA). A modified Bruce 
treadmill protocol with a constant treadmill speed (5.5 
km• h-1) and increases in treadmill gradient (1% per 
minute) was used during the stress test. On-line gas 
analysis was completed during stress testing. Inspired 
air volume was measured by a calibrated turbine 
Ventilation Monitor (Morgan Mk 2, USA). 
Participants’ expired air was collected in 3L mixing 
chambers via a Hans Rudolph low resistance valve. 
Expired air samples were drawn from a mixing 
chamber and dried. Each minute sample was analysed 
for O2 and CO2 using O2 (Morgan Mk 701) and CO2 
(Morgan) gas analysers calibrated against two alpha 
standard gases of known compositions. The stress test 
was terminated when the participant reached his peak 
aerobic capacity as indicated by a heart rate plateau at 
high work intensities. As described in the study 
design, only participants with a peak aerobic capacity ( 
) of 40 ml• kg-1• min-1 or less were included in this 
study. 
Electrocardiograms (ECGs) were recorded at rest and 
during exercise during each of the three testing 
sessions and were conducted and interpreted by a 
cardiologist. A 12-lead ECG was taken immediately 
prior to commencing the exercise test with the 
participant remaining stationary and standing on the 
treadmill. The exercising electrocardiograms were 
recorded during the treadmill exercise tests. 
Interpretation of both the resting and exercising 
electrocardiographs involved identifying persistent ST 
segment depression (at least 1mm that is horizontal or 
down-sloping at 0.08 seconds after the J point) 
because, according to the American College of Sports 
Medicine (19), an ST segment depression that occurs 
early and remains throughout testing is more likely to 
be due to coronary heart disease than an ST depression 
that occurs only during high intensity exercise. Heart 
rates were determined directly from the ECG trace. 
Resting systolic blood pressure (SBP) and resting 
diastolic blood pressure (DBP) recordings were 
determined indirectly, with a sphygmomanometer cuff 
placed on the left arm using the Quinton 5000 
Exercise Test Monitor. All cardiovascular variables 
were monitored for 30 minutes after completion of the 
exercise test. 
 
Physical Activity Programme 
 
Participants in the experimental group completed a 12-
week aerobic physical activity program that was 
designed in accordance with American College of 
Sports Medicine guidelines (19). Each week 
comprised a combination of supervised and 
unsupervised walking or jogging that gradually 
increased during the first eight weeks from 10 minutes 
performed 3 days per week to 45 minutes performed 5 
days per week. Target heart rate reserve values of 50-
60% were calculated for each participant based upon 
resting and maximum values recorded during their 
stress tests.  Participants monitored their own heart 
rates throughout each exercise session and regulated 
their efforts accordingly. Individual relative exercise 
intensity was more difficult to control during the less 
frequent supervised group-based training sessions, 
with the result that some participants occasionally 




Between-group comparisons (exercise vs. sedentary) 
were made using between-subjects one-way ANOVAs 
with an alpha level of 0.05 to indicate significance. 
Comparisons between the trials (0, 6, and 12 weeks) 
were made using repeated-measures ANOVAs and 
post-hoc paired samples t-tests with a Bonferonni 
corrected alpha level of 0.0167 to indicate 
significance. All values are presented as the mean ± 
one standard deviation and effect sizes for significant 






At week 0 (pre-trial) there were no differences 
between the exercise and sedentary groups for age 
(42.4±1.4 years vs. 44.5±1.5 years, p>0.05), height 
(177.7±1.2 cm vs. 175.7±1.7 cm, p>0.05), body mass 
(80.6±1.9 kg vs. 85.7±3.3 kg, p>0.05) or percentage 
body fat (21.5±0.7% vs. 21.8±0.5%, p>0.05). There  
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Figure 1. Change in aerobic capacity between exercise and 
sedentary groups. ** p < 0.01 (compared with week 0) 
 
 
was no significant reduction in body mass between 
week 0 and week 12 among either the sedentary group 
(86.7±3.3 kg vs. 85.8±3.4 kg, p>0.0167) or the 
exercise group (80.6±1.9 kg vs. 78.7±1.7 kg, 
p>0.0167). However, a reduction in the percentage of 
body fat between week 0 and week 12 was evident 
among the exercise group (from 21.8±0.5% to 
19.5±0.5%, p<0.0167, g=-4.5) but not among the 




At week 0 there were no differences between the 
groups in resting heart rate (p > 0.05), SBP (p>0.05) or 
DBP (p>0.05). Between week 0 and week 12 there 
was a reduction in resting heart rate among the 
exercise group (from 73±2 beats•min-1to 68±2 
beats•min-1, p<0.0167, g=-2.5) but not among the 





At week 0 there were no differences between the 
groups in resting heart rate (p > 0.05), SBP (p>0.05) or 
DBP (p>0.05). Between week 0 and week 12 there 
was a reduction in resting heart rate among the 
exercise group (from 73±2 beats•min-1to 68±2 
beats•min-1, p<0.0167, g=-2.5) but not among the 
sedentary group (72±3 beats•min-1 vs. 73±3 
beats•min-1, p>0.0167). There were no changes in 
SBP (p>0.0167) or DBP (p>0.0167) among the 
exercise group, but a reduction in SBP (from 132±3 
mm Hg to 120±3 mm Hg, p<0.01, g=-3.9) and DBP 
(from 85 mm±2 Hg to 79±2 mm Hg, p<0.01, g=-2.9) 
was observed among the sedentary group. 
At week 0 there was no difference between the groups 
in  (p>0.05). Between week 0 and week 12 there was a 
significant increase in among the exercise group (from 
33±4 mL•kg-1•min-1 to 40±4 mL•kg-1•min-1, 
p<0.01, g=5) but not among the sedentary group (32±7 
mL•kg-1•min-1 vs. 32±5 mL•kg-1•min-1 , p>0.0167). 
Changes in   are presented in Figure 1. 
 
Serum Lipid Concentrations 
 
At week 0 there were no differences between the 
groups for CHOL (p>0.05) or TRIG (p>0.05). 
Between week 0 and week 12 there was a decrease in 
CHOL among both the sedentary group (from 6.1±0.3 
mmol•L-1 to 5.3±0.2 mmol•L-1, p<0.01, g=-3.1) and 
the exercise group (from 6.1±0.3 mmol•L-1 to 5.0±0.2 
mmol•L-1, p<0.01, g=-4.2). Between week 0 and 
week 12 there was a reduction in TRIG among the 
exercise group (from 1.8±0.3 mmol•L-1 to 1.2±0.2 
mmol•L-1, p<0.01, g=-2.3) but not among the 
sedentary group (1.7±0.1 mmol•L-1 vs. 1.7±0.1 
mmol•L-1, p>0.0167). 
At week 0 there were no differences between the 
groups for Apo-A1 (p>0.05) or Apo-B (p>0.05). 
Between week 0 and week 12 there were no changes 
in Apo-A1 among the exercise group (1.15±0.06 g•L-1 
vs. 1.10±0.06 g•L-1, p>0.0167) or the sedentary group 
(1.06±0.03 g•L-1 vs. 1.06±0.03 g•L-1, p>0.0167). 
Compared with week 0, Apo-B levels among the 
exercise group had decreased by week 6 (from 
0.94±0.18 g•L-1 to 0.81±0.18 g•L-1, p<0.0167, g=-
0.7) and were still lower at week 12 (from 0.94±0.18 
g•L-1 to 0.78±0.18 g•L-1, p<0.0167, g=-0.9). There 
were no changes in Apo-B levels among the sedentary 
group between week 0 and week 6 (0.95±0.27 g•L-1 
vs. 0.89±0.22 g•L-1, p>0.0167, g=-0.2) or between 
week 0 and week 12 (0.95±0.27 g•L-1 vs. 0.88±0.36 
g•L-1, p>0.0167). All serum lipid and apolipoprotein 
concentration values are presented in Table 1. 
Between week 0 and week 12 there was an increase in 
the Apo-A1:Apo-B ratio among the exercise group 
(from 1.17±0.22 to 1.4±0.27, p<0.0167, g=0.9) but not 
among the sedentary group (1.28±0.49 vs. 1.41±0.49, 
p>0.0167). There were no trial or group differences in 
the HDL:CHOL ratio (p>0.05), the LDL:CHOL ratio 
(p>0.05) or the LDL:HDL ratio (p>0.05). All serum 





Compared with sedentary controls, participants who 
exercised showed an increase in peak aerobic capacity 
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Table 1. Exercise and sedentary group serum lipid concentration values. 
 Week 0 Week 6 Week 12 
 Sedentary Exercise Sedentary Exercise Sedentary Exercise 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Cholesterol (mmol· L-1) 6.1     (1.3) 6.1     (1.3) 5.9     (1.3) 5.4     (1.3)* 5.3     (0.9)** 5.0  (0.9)** 
Triglyceride (mmol· L-1) 1.7     (0.4) 1.8     (1.3) 1.7     (0.9) 1.5     (0.9) 1.7     (0.4) 1.2  (0.4)** 
H.D.L (mmol· L-1) 1.34    (0.4) 1.28 (0.27) 1.17  (0.4)* 1.08 (0.18)* 1.15 (0.53) 1.16 (0.22) 
L.D.L (mmol· L-1) 4.01   (1.3) 3.97 (1.12) 3.80 (1.34) 3.43 (0.98)* 3.34 (1.34)* 3.29 (0.94)* 
Apo A-1 (mmol· L-1) 1.15 (0.27) 1.06 (0.13) 1.14 (0.22) 1.04 (0.13) 1.10 (0.27) 1.06 (0.13) 
Apo B (mmol· L-1) 0.95 (0.27) 0.94 (0.18) 0.89 (0.22) 0.81 (0.18)* 0.88 (0.36) 0.78 (0.18)* 
* p<0.0167  
** p<0.01 (from baseline at Week 0) 
 
adiposity, serum triglyceride, and Apo-B, which is 
consistent with our hypothesis. However, both 
sedentary and exercise groups showed reductions in 
total serum cholesterol and LDL. These results suggest 
that sedentary people who regularly participate in light 
aerobic exercise for even a short period can reduce 
their CHD risk, as indicated by changes in the Apo A-
1:Apo B ratio, an accepted measurement of CHD 
susceptibility (5-11). Contrary to other studies (25, 
27), our findings add that light exercise, typically 
prescribed to people with CHD risk factors, can have 
beneficial effects within a relatively short period. 
The observed changes in body composition in both the 
sedentary and the exercise groups were as expected 
and correspond with similar alterations in weight and 
percentage of body fat that have been observed in 
adult males during 20- and 24-week aerobic exercise 
programmes (13, 20, 21). Only the exercise group 
showed a reduction in adiposity during the current 
study, suggesting that even light regular exercise can 
cause beneficial physiological changes among 
sedentary people in a relatively short period. 
Peak aerobic capacity also responded as expected in 
both the sedentary and the exercise groups. When the 
changes observed in the exercising participants are 
compared with the sedentary controls, it appears likely 
that the aerobic exercise regime followed during this 
study contributed to the change. Many studies have 
shown that maximal aerobic capacity is positively 
correlated with levels of activity in an individual (13, 
20-23). However, studies also show that there is no 
direct association between plasma lipoprotein 
concentrations and cardiorespiratory fitness, 
particularly in ‘low exercise’ study groups (24-26). 
Heart rate and blood pressure responses were as 
expected and are consistent with other well-
documented studies (13, 27, 28). 
Serum triglyceride levels fell only among the 
exercising participants but, unexpectedly, serum 
cholesterol levels fell among both groups. Our 
findings also suggest that changes in LDL 
concentration are more sensitive to low intensity 
aerobic physical activity than changes in HDL since 
both the sedentary and the exercise groups showed no 
change in HDL. Previous studies have suggested that 
lipoprotein measurements can be influenced by 
sampling time and method, suppressed baseline 
lipoprotein levels and factors such as body weight, 
age, diet, smoking and intensity of exercise (9, 24, 29, 
30). Since all of these factors were carefully controlled 
in our study, we conclude that light exercise has 
selected short-term benefits, with serum triglyceride 
responding the most. In fact, it is apparent from other 
studies that traditional lipoprotein measures do not 
change consistently in response to various exercise 
programs. While one study found that LDL fell among 
30-45 year old males after a one-year exercise 
program (31), other studies observed reductions in 
CHOL, LDL and non-HDL only after a 24-week high 
intensity exercise program (20) or among men aged 
over 50 years (29). We conclude from our results, 
along with the inconsistent outcomes of other studies, 
that the use of traditional lipoprotein levels to evaluate 
CHD risk factors may be an unreliable predictor, 
especially when low intensity short-duration exercise 
interventions are used. 
Throughout the study, Apo-A1 concentrations 
remained constant among the exercise and the 
sedentary groups. Apo-B concentrations were lower in 
the exercise group but remained unchanged in the 
sedentary group. These results differ from previous 
apolipoprotein studies. For instance, in one such study, 
a group of active males showed significantly higher 
Apo-A1 levels than matched controls when subjects  
had been exercising for a minimum of two years (17). 
This result was accompanied by a significant reduction 
in HDL, but no change in LDL. Similar data was 
obtained in a study into the effect of inactivity on  
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serum lipid concentrations (32). Patients who were 
confined to hospital beds showed highly significant 
reductions in both Apo-A1 and HDL after 3-6 weeks. 
Remarkably, serum cholesterol concentrations actually 
decreased significantly in comparison with those of 
active controls. It was concluded that daily activity 
was accompanied by an increase in both HDL and 
Apo-A1, but may not be accompanied by a decrease in 
serum cholesterol (32). However, these studies 
involved either long-term exercise or extremely 
sedentary behavior, which makes direct comparisons 
with our own findings difficult. What our findings add 
is that in the short term light physical activity has a 
beneficial effect on Apo-B but not on Apo-A1 
concentrations. 
More recent studies report more varied and 
inconsistent findings. For example, Fung et al. (33) 
studied a large group of healthy men in relation to the 
impact that physical activity level (using average 
metabolic equivalent-hours per week) had upon lipid 
profiles. They found that Apo-A1 level variation was 
not related to average physical activity level, despite a 
positive association between level of physical activity 
and HDL (33). Fung et al. did, however, identify an 
inverse relationship between sedentary activity (hours 
spent watching television) and Apo-A1 levels in the 
same group of individuals. Couillard et al. (30) 
discovered that favorable effects on lipid profiles 
following a 20-week exercise programme (decreases 
in CHOL, LDL, TRIG and Apo-B levels, and an 
increase in Apo-A1 and HDL) were restricted to men 
with high baseline levels of triglyceride and LDL. As a 
result of this study, Couillard et al. proposed that 
discrepancies in HDL and Apo-A1 in response to 
exercise are independent of one another and that there 





An increase in the Apo-A1:Apo-B ratio was evident 
only among the exercising group, suggesting that this 
measure is sensitive to light exercise and responds in a 
relatively short period. The increase in the ratio 
appears to be due mainly to a greater reduction of 
Apo-B concentration among the exercising group than 
has been previously discussed. As other studies have 
suggested, the Apo-A1:Apo-B ratio appears to be an 
effective way of evaluating CHD risk (6, 34). Our 
study adds that this method is appropriate for 
monitoring CHD risk factor change during short-term 
light-exercise interventions.  
It is a strength of the present study that the treatment 
conditions involved mild aerobic physical activity to 
reflect the intensity of exercise that is considered to be 
safe and which is typically prescribed to improve the 
prognosis of patients with CVD risk factors. The main 
limitation of our study is the relatively short data 
collection period. What is needed in the future is a 
more detailed examination of how light exercise 
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